Browning, SM. Office management of common anorectal problems. Prim. Care 1999; 26:113–21
Feldman, J. H. Epidemidogy. In Feldman, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 6th edition. Philadelphia: WB Saunders; 1998. p. 692
Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992; 102:895–901, , and
AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116:6 and
Talan, D. A., Moran, G. J., Ong, S., et al. Prevalence of E. coli O157: H7 and other enteropathogens among patients presenting to US emergency departments with bloody diarrhea. In Abstracts of the International Conference on Emerging Infectious Diseases (Atlanta), 8–11 March 1998
Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 2001; 32:1001, , and
Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 1997; 92:1962–75
Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double blind, randomized, controlled trial. Ann. Intern. Med. 1997; 126:697–703, , , and
The irritable bowel. Gut 1984; 25:305–11
Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987; 92:1282–9 and
The epidemiology of iritable bowel syndrome in North America. A systemic review. Am. J. Gastroenterol. 2002; 97:1910–15, and
Irritable bowel syndrome. Prim. Care. 2001; 28:147–62
Evidence for autonomic dysregulation in the irritable bowel syndrome. Dig. Dis. Sci. 2002; 47:1716–22, and
Gastrointestinal motility in patients with the irritable bowel syndrome. Scan. J. Gastroenterol. Suppl. 1987; 130:21–9
Irritable bowel syndrome in office based practice in the United States. Gastroenterology 1991; 100:998–1003 and
Abuse history and chronic pain in women II: a multivariate analysis of abuse and psychological morbidity. Obstet. Gynecol. 1994; 84:200–206, , , et al.
Alosetron for irritable bowel syndrome. Br. Med. J. 2002; 325:555
Long term safey of tegaserod in patients with constipation predominant irritable bowel syndrome. Aliment. Pharmocol. Ther. 2002; 16:1701–8, , , et al.
Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects. Am. J. Gastroenterol. 2002; 97:2321–7, , , et al.
Urinary incontinence in women from 35 to 79 years of age: prevalence and consequences. Eur. J. Obstet. Gynecol. Reprod. Biol. 1992; 43:229–34, , and
Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J. Urol. 1991; 146: 1255–9, and
The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 1993 22:82–9, , , and
The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population. Acta Obstet. Gynecol. Scand. 1999; 78:546–51, , , and
Female urinary incontinence – consultation behaviour and patient experiences: an epidemiological survey in a Norwegian community. Fam. Pract. 1995; 12:18–21, , and
Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet. Gynecol. 1999; 94:66–70, , , et al.
Promoting urinary continence in women after delivery: randomised controlled trial. Br. Med. J. 2002; 324:1241 and
Postnatal incontinence: a multicenter randomised controlled trial of conservative treatment. Br. J. Obstet. Gynaecol. 1998; 105:47, , , et al.
Treatment of urinary incontinence in women in general practice: observational study. Br. Med. J. 1996; 312:1459–62, and
(CE-4) Conservative treatment of stress urinary incontinence in women: a systematic review of randomised trialBr. J. Urol. 1998; 82:181–91, , et al.
(C) Hay-Smith, E. J. C., Bo, K., Berghmans, L. C. M., et al. Pelvic floor muscle training for urinary incontinence in women. In The Cochrane Library, issue 2. Oxford: Update Software; 2002
Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta analysis. Obstet. Gyencol. 1994; 83:12–18, , , et al.
(CE-4) Single blind randomised controlled trial of pelvic floor exercise, electronical stimulation, vaginal cones and no treatment in the mangement of genuine stress incontinence. Br. Med. J. 1999; 318:4487–93, and
(C) Glazener, C M. A. and Cooper, K. Anterior vaginal repair for urinary incontinence in women. In The Cochrane Library, issue 2. Oxford: Update Software; 2002
(C) Bezerra, C. A. and Bruschini, H. Suburethral sling operations for urinary incontinence in women. In The Cochrane Library, issue 2. Oxford: Update Software; 2002. www.update-software.com/abstracts/ab001754.htm
(AHRQ – A recommendation) The effects of changing prompted voiding schedules in the treatment of incontinence in nursing home residents. J. Am. Geriatr. Soc. 1994; 42:315–20, , , et al.
(C) Roe, B., Williams, K. and Palmer, M. Bladder training for urinary incontinence in adults. In The Cochrane Library, issue 2. Oxford: Update Software; 2002
Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. Am. J. Obstet. Gynecol. 2001; 185:56–61
Behvioral vs. drug treatment for urge urinary incontinence in older women. J. Am. Med. Assoc. 1998; 280:1995–2001, , , et al.
Randomised trial of cranberry ligonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. Br. Med. J. 2001; 322:1571, , , et al.
A prospective study of risk factor for urinary tract infection in young women. N. Engl. J. Med. 1996; 335:468–74, , , et al.
Incidence of acute urinary tract infection in young women and use of male condoms with and without nonosynol-9 spermicides. Epidemiology 2002; 13:431–6, , and
Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann. Intern. Med. 2001; 135:51–2, , and
Disappointing dipstick screening for urinary tract infection in hospital inpatients. J. Clin. Pathol. 1998; 51:471–2, , , et al.
Does this woman have an uncomplicated urinary tract infection. J. Am. Med. Assoc. 2002; 287:2701–10, , , and
Value of urological investigation in a targeted group of women with recurrent urinary tracts. Can. J. Surg. 1991; 34:591–4, , and
Radiological abnormalities in women admitted with pyelonephritis. Del. Med. J. 1987; 59:717–19
Fluoroguinolones in the treatment of acute uncomplicated urinary tract infections in adult women. Expert Opin. Pharmacother. 2001; 2:1227–37 and
Antibiotic resistence in bacterial urinary tract infections 1991 to 1997. West. J. Med. 1998; 169:265–8, and
Recurring urinary tract infection: incidence and risk factors. Am. J. Publ. Health 1990; 80:331
Antimicrobial prophylaxis of recurrent urinary tract infections: a double blind placebo controlled trial. Ann. Intern. Med. 1980; 92:770–75, , , et al.
Post intercourse versus daily ciprofloxin prophylaxis for recurrent urinary tract infections in premenopausal women. J. Urol. 1997; 157:935–9, , , et al.
A randomized open, parallel-group study on the preventive effect of an estradiol releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am. J. Obstet. Gynecol. 1999; 180:1072–9